M&T Bank’s Eli Lilly LLY Stock Holding History

M&T Bank’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-6	Closed	-$1K	–	1652
2019 Q1	$1K	Buy	+6	New	+$730	﹤0.01%	1585

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

M&T Bank's LLY Position: Q1 2026 in Review

M&T Bank reduced its Eli Lilly (LLY) stake by 4% in Q1 2026, selling an estimated $10.3M and leaving 240,540 shares worth $221M. The position accounts for 0.76% of the portfolio, ranked #26.

M&T Bank first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $269M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

M&T Bank held 240,540 shares of Eli Lilly worth $221M as of Q1 2026.
M&T Bank sold 10,152 Eli Lilly shares in Q1 2026, an estimated $10.3M.
Eli Lilly made up 0.76% of M&T Bank's portfolio in Q1 2026, its #26 holding.
M&T Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
M&T Bank's Eli Lilly position peaked at $269M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.